Gulf International Bank UK Ltd cut its stake in Docusign Inc. (NASDAQ:DOCU - Free Report) by 28.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,323 shares of the company's stock after selling 4,516 shares during the period. Gulf International Bank UK Ltd's holdings in Docusign were worth $921,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of the stock. New Age Alpha Advisors LLC lifted its position in Docusign by 738.2% during the first quarter. New Age Alpha Advisors LLC now owns 41,187 shares of the company's stock valued at $3,353,000 after buying an additional 36,273 shares in the last quarter. Pinpoint Asset Management Ltd lifted its position in Docusign by 54.3% during the first quarter. Pinpoint Asset Management Ltd now owns 56,985 shares of the company's stock valued at $4,639,000 after buying an additional 20,043 shares in the last quarter. Concurrent Investment Advisors LLC acquired a new position in Docusign during the first quarter valued at approximately $618,000. Gilman Hill Asset Management LLC lifted its position in Docusign by 4.9% during the first quarter. Gilman Hill Asset Management LLC now owns 84,326 shares of the company's stock valued at $6,864,000 after buying an additional 3,904 shares in the last quarter. Finally, Blair William & Co. IL lifted its position in Docusign by 1.7% during the first quarter. Blair William & Co. IL now owns 387,542 shares of the company's stock valued at $31,546,000 after buying an additional 6,460 shares in the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Docusign
In other Docusign news, CEO Allan C. Thygesen sold 40,000 shares of the company's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $77.51, for a total value of $3,100,400.00. Following the completion of the sale, the chief executive officer directly owned 143,983 shares of the company's stock, valued at approximately $11,160,122.33. This represents a 21.74% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 15,143 shares of the company's stock in a transaction dated Wednesday, June 18th. The shares were sold at an average price of $74.80, for a total transaction of $1,132,696.40. Following the completion of the sale, the chief financial officer directly owned 110,723 shares of the company's stock, valued at $8,282,080.40. The trade was a 12.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 78,552 shares of company stock valued at $5,983,631 over the last 90 days. Insiders own 1.66% of the company's stock.
Docusign Trading Down 0.1%
DOCU traded down $0.0770 on Wednesday, reaching $70.8030. The company had a trading volume of 800,560 shares, compared to its average volume of 2,583,864. The company has a fifty day moving average of $75.66 and a 200-day moving average of $80.78. The company has a market capitalization of $14.31 billion, a P/E ratio of 13.38, a PEG ratio of 26.76 and a beta of 1.01. Docusign Inc. has a one year low of $54.31 and a one year high of $107.86.
Docusign (NASDAQ:DOCU - Get Free Report) last announced its earnings results on Thursday, June 5th. The company reported $0.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.81 by $0.09. The firm had revenue of $763.65 million during the quarter, compared to analyst estimates of $748.79 million. Docusign had a net margin of 36.50% and a return on equity of 14.27%. Docusign's revenue was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.82 EPS. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Research analysts predict that Docusign Inc. will post 1.17 EPS for the current year.
Docusign announced that its Board of Directors has authorized a share buyback plan on Thursday, June 5th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to repurchase up to 6.6% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's management believes its shares are undervalued.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on DOCU shares. Robert W. Baird reduced their price target on shares of Docusign from $93.00 to $85.00 and set a "neutral" rating on the stock in a research report on Friday, June 6th. Wells Fargo & Company raised shares of Docusign from an "underweight" rating to an "equal weight" rating and boosted their target price for the stock from $67.00 to $80.00 in a research report on Friday, June 13th. UBS Group reduced their target price on shares of Docusign from $85.00 to $80.00 and set a "neutral" rating on the stock in a research report on Friday, June 6th. Wedbush cut their price target on shares of Docusign from $100.00 to $85.00 and set a "neutral" rating on the stock in a report on Thursday, June 12th. Finally, Citigroup cut their price target on shares of Docusign from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Monday, June 9th. Four investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $89.77.
Check Out Our Latest Report on Docusign
About Docusign
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also

Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.